IFF Oct 2024 92.500 call
| Previous close | 7.45 |
| Open | 8.20 |
| Bid | 8.10 |
| Ask | 8.70 |
| Strike | 92.50 |
| Expiry date | 2024-10-18 |
| Day's range | 8.20 - 8.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 56 |
Business WireIFF Details Sustainability Leadership in 2023 Do More Good Report
NEW YORK, May 29, 2024--IFF (NYSE:IFF) today released its 2023 Do More Good Report, describing how the Company is progressing against its environmental, social, governance, and sustainable solutions (or ESG+) strategy across the organization. The report showcases that IFF enabled customers and consumers to avoid approximately 24.6 million tonnes of CO2e emissions using IFF innovations, amongst other achievements. The new report can be experienced by visiting iff.com/domoregoodreport.
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PR NewswireIFF to Unveil Breakthrough Alginate Technologies for Biomedical Innovation at WBC and TERMIS
IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health will unveil groundbreaking study results at upcoming major biomedical conferences. These results highlight how IFF Pharma Solutions NovaMatrix® portfolio of ultrapure alginate biopolymers could revolutionize regenerative medicine and 3D cell culture applications. At the 12th World Biomaterials Congress (WBC), IFF Pharma Solutions will showcase a first-of-its-kind alginate hydrogel system that self-gels, offe
